Skip to main content
Fig. 5 | Molecular Neurodegeneration

Fig. 5

From: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

Fig. 5

Common dementia markers for LBD and AD. Results of the targeted proteomic multiplexed assay of protein biomarkers quantitated in the CSF. Graphs a-m show significant changes in Lewy body dementia, and Alzheimer’s disease compared to controls. No significant changes are observed in the PD group * Denotes new biomarkers not described previously

Back to article page

Molecular Neurodegeneration

ISSN: 1750-1326